Antinociceptive effects of the novel spirocyclopiperazinium salt compound LXM-10 in mice

Pharmacology Biochemistry and Behavior

Volumn 86, Issue 4, 2007, Pages 643-650

  Yue, Cai Qin ^a   Ye, Jia ^a   Li, Chang Ling ^a   Li, Run Tao ^a   Sun, Qi ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Antinociception; LXM 10

Indexed keywords

2,4 DIMETHYL 9 BETA PHENYLETHYL 3 OXO 6,9 DIAZASPIRO[5.5]UNDECANE CHLORIDE; ACETIC ACID; ANTINOCICEPTIVE AGENT; ATROPINE; ATROPINE METHYL NITRATE; DIAZEPAM; HEXAMETHONIUM; LXM 10; MECAMYLAMINE; MORPHINE; NALOXONE; PIPERAZINE DERIVATIVE; UNCLASSIFIED DRUG; YOHIMBINE;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; BODY TEMPERATURE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFECT; DRUG STRUCTURE; FEMALE; HOT PLATE TEST; MALE; MOTOR COORDINATION; MOUSE; NONHUMAN; PHYSICAL ACTIVITY; PRIORITY JOURNAL;

ANALGESICS; ANIMALS; ATROPINE; ATROPINE DERIVATIVES; BODY TEMPERATURE; DRUG EVALUATION, PRECLINICAL; FEMALE; HEXAMETHONIUM; MALE; MECAMYLAMINE; MICE; MICE, INBRED ICR; MOTOR ACTIVITY; NALOXONE; PAIN; PAIN MEASUREMENT; PIPERAZINES; PSYCHOMOTOR PERFORMANCE; RECEPTORS, ADRENERGIC, ALPHA-2; RECEPTORS, MUSCARINIC; RECEPTORS, NICOTINIC; RECEPTORS, OPIOID; YOHIMBINE;

MUS;

EID: 34249696025     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2007.02.009     Document Type: Article

References (39)

1. Bannon A.W., Gunther K.L., and Decker M.W. Is epibatidine really analgesic? Dissociation of the activity, temperature, and analgesic effects of (+)-epibatidine. Brain Res 51 4 (1995) 693-698
2. Bannon A.W., Decker M.W., Holladay M.W., Curzon P., Donnelly-Roberts D., Puttfarcken P.S., et al. Broad-spectrum, non-opioid analgesic activity by selective modulation of neuronal nicotinic acetylcholine receptors. Science 279 (1998) 77-81
3. Barocelli E., Calcina F., and Chiavarini M. Antinociceptive and gastroprotective effects of inhaled and orally administered Lavandula hybrida Reverchon "Grosso" essential oil. Life Sci 76 (2004) 213-223
4. 2) effects on C-nociceptors in isolated rat skin. J Neurosci 21 (2001) 3295-3302
5. 2 receptors inhibit heat-induced CGRP release from isolated rat skin, in vitro. NeuroReport 2 (2001) 2457-2460
6. Chaim G.P., Yakov C., Tova R., Kenner C.R., and Shaul S. The antinociceptive effect of zolpidem and zopiclone in mice. Pharmacol Biochem Behav 81 (2005) 417-423
7. Davis L., Pollock L.J., and Stone T. Visceral pain. Surg Gynecol Obstet 55 (1932) 418-426
8. Decker M.W., Buckley M.J., and Brioni J.D. Differential effects of pretreatment with nicotine and lobeline on nicotine-induced changes in body temperature and locomotor activity in mice. Drug Devel Res 31 (1994) 52-58
9. Dina M., Alessandro B., Pier A.B., Cristina B., Silvia D., Carla G., et al. Hybridized and isosteric analogues of N1-acetyl-N4-dimethyl-piperazinium iodide (ADMP) and N1-phenyl-N4-dimethyl-piperazinium iodide (DMPP) with central nicotinic action. Bioorganic Med. Chem 7 (1999) 457-465
10. Eddy N.B., and Leimbach D. Synthetic analgesics: II. dithienylbutenyl and dithienylbutylamines. J Pharmacol Exp Ther 107 (1953) 385-393
11. Elisabetta B., Vigilio B., Simona B., and Marco D.A. Mariannina I. Evidence for specific analgesic activity of a muscarinic agonist selected among a new series of acetylenic derivatives. Life Sci 68 (2001) 1775-1785
12. Gao F.L., Wang X., Zhang H.M., Cheng T.M., and Li R.T. Unique spirocyclopiperazinium salt I: synthesis and structure-activity relationship of spirocyclopiperazinium salts as analgesics. Bioorg Med Chem Lett 13 (2003) 1535-1537
13. Gotti C., and Clementi F. Neuronal nicotinic receptors: from structure to pathology. Prog Neurobiol 74 (2004) 363-396
14. Hartvig P., Gillberg P.G., Gordh J.T., and Post C. Cholinergic mechanisms in pain and analgesia. Trends Pharmacol Sci 10 (1989) 75-79 [Suppl]
15. Iwamoto E.T., and Marion L. Characterization of the antinociception produced by intrathecally administered muscarinic agonists in rats. J Pharmacol Exp Ther 266 (1993) 329-338
16. James C.E. Muscarinic-induced analgesia. Life Sci 64 6/l (1999) 549-554
17. Jürgen W., Alokesh D., and Jesus G. Muscarinic receptor subtypes mediating central and peripheral antinociception studied with muscarinic receptor knockout mice: a review. Life Sci 72 (2003) 2047-2054
18. Khan I.M., Osaka H., Stanislaus S., Calvo R.M., Deenrinc T., Yaksh T.L., et al. Nicotinic acetylcholine receptor distribution in relation to spinal neurotransmission pathways. J Comp Neurol 467 (2003) 44-59
19. Kingery W.S. A critical review of control clinical trials for peripheral neuropathic pain and complex regional pain syndromes. Pain 7 (1997) 123-139
20. Koster R., Anderson M., and De Beer E.J. Acetic acid for analgesic screening. Fed Proc 18 (1959) 412
21. Le Novere N., and Changeux J.P. Molecular evolution of the nicotinic acetylcholine receptor: an example of multigene family in excitable cells. J Mol Evol 40 (1995) 155-172
22. Lindstrom J. The structures of neuronal nicotinic receptors. In: Clementi F., Fornasari D., and Gotti C. (Eds). Handbook of experimental pharmacology vol. neuronal nicotinic receptors (2000), Springer, Berlin 101-162
23. Marubio L.M. Reduced antinociception in mice lacking neuronal nicotinic receptor subunits. Nature 398 (1999) 805-810
24. McQuay H.J., Tramer M., Nye B.A., Carroll D., Wiffen P.J., and Moore R.A. A systematic review of antidepressants in neuropathic pain. Pain 68 (1996) 217-227
25. Michael W.D., Anthony W.B., Michael J.B., David J.B.K., Mark W.H., Keith B.R., et al. Antinociceptive effects of the novel neuronal nicotinic acetylcholine receptor agonist, ABT-594, in mice. Euro J Pharmacol 346 (1998) 23-33
26. Michael W.D., Lynne E.R., and Scott Bitner R. Nicotinic acetylcholine receptor agonists: a potential new class of analgesics. Curr Top Med Chem 4 (2004) 369-384
27. Millan M.J. The induction of pain: an integrative review. Prog Neurobiol 57 (1999) 1-64
28. Millan M.J. Descending control of pain. Prog Neurobiol 66 (2002) 355-474
29. Naguib M., and Yaksh T.L. Characterization of muscarinic receptor subtypes that mediate antinociception in the rat spinal cord. Anesth Analg 85 (1997) 847-853
30. Przewlocki R., and Przewlocka B. Opioids in chronic pain. Eur J Pharmacol 429 (2001) 79-91
31. Rodrigues A.L.S., Da Silva G.L., Mateussi A.S., Fernandes E.S., Miguel O.G., Yunes R.A., et al. Involvement of monoaminergic system in the antidepressant-like effect of the hydroalcoholic extract of Siphocampylus verticillatus. Life Sci 70 (2002) 1347-1358
32. Romanelli M.N., Manetti D., Scapecchi S., Borea P.A., Dei S., Bartolini A.G., et al. Structure-affinity relationships of a unique nicotinic ligand: N-1-dimethyl-N-4-phenylpiperazinium iodide (DMPP). J Med Chem 44 (2001) 3946-3955
33. Rosland J.H., Hunskaar S., and Hole K. Diazepam attenuates morphine antinociception test-dependently in mice. Pharmacol Toxicol 66 (1990) 382-386
34. Sullivan J.P., Donnelly-Roberts D., and Briggs C.A. ABT-089 [2-methyl-3(2-(S)-pyrrolidinylmethoxy) pyridine]: a potent and selective cholinergic channel modulator with neuroprotective properties. J Pharmacol Exp Ther 283 (1997) 235-246
35. Swedberg M.D., Sheardown M.J., Sauerberg P., Olesen P.H., Suzdak P.D., Hansen K.T., et al. Butylthio[2.2.2] (NNC 11-1053/LY297802): an orally active muscarinic agonist analgesic. J Pharmacol Exp Ther 281 (1997) 876-883
36. Tadimeti S.R., Lucia D.C., Richard T.R., and Kennethlloyd G. Evaluation of anti-nociceptive effects of neuronal nicotinic acetylcholine receptor. Neurophamacology 35 4 (1996) 393-405
37. Wang X., Gao F.L., Piao H.B., Cheng T.M., and Li R.T. Unique spirocyclopiperazinium salt. Part 2: synthesis and structure-activity relationship of dispirocyclopiperazinium salts as analgesics. Bioorg Med Chem Lett 13 (2003) 1729-1732
38. Wang X., Sha Y.W., and Li R.T. Fragmentation patterns of novel dispirocyclopiperazinium dibromides with strong analgesic activity under electrospray ionization tandem mass spectrometry conditions. Int J Mass Spectrom 235 (2004) 111-115
39. Zimmermann P. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16 (1983) 109-110